These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1805727)

  • 21. [Effect of exogenous proteinases on blood coagulation factors].
    Geĭtman IIa; Kardash BE; Kivman GIa
    Probl Gematol Pereliv Krovi; 1982 Oct; 27(10):38-44. PubMed ID: 6757917
    [No Abstract]   [Full Text] [Related]  

  • 22. In vivo modelling of coagulation factor concentrate thrombogenicity.
    MacGregor I; Drummond O; Prowse C
    Thromb Haemost; 1997 Feb; 77(2):405-6. PubMed ID: 9157607
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of defibrinogenation with batroxobin on endotoxin-induced disseminated intravascular coagulation in rats.
    Yoshikawa T; Murakami M; Furukawa Y; Takemura S; Kato H; Kondo M
    Thromb Res; 1983 Sep; 31(5):729-35. PubMed ID: 6359574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age and dose sensitivities in the 2-butoxyethanol F344 rat model of hemolytic anemia and disseminated thrombosis.
    Ramot Y; Lewis DA; Ortel TL; Streicker M; Moser G; Elmore S; Ward SM; Peddada S; Nyska A
    Exp Toxicol Pathol; 2007 Apr; 58(5):311-22. PubMed ID: 17261363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential thrombogenicity of heat-treated prothrombin complex concentrates in Haemophilia B.
    Hampton KK; Makris M; Kitchen S; Preston FE
    Blood Coagul Fibrinolysis; 1991 Oct; 2(5):637-41. PubMed ID: 1782333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prothrombin complex preparations: a cautionary note.
    Ratnoff OD
    Ann Intern Med; 1974 Dec; 81(6):852-3. PubMed ID: 4433087
    [No Abstract]   [Full Text] [Related]  

  • 27. Acute coagulopathy following infusion of prothrombin complex concentrate.
    Davey RJ; Shashaty GG; Rath CE
    Am J Med; 1976 May; 60(5):719-22. PubMed ID: 1020759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disseminated intravascular coagulation and myocardial infarction in a haemophilia B patient during therapy with prothrombin complex concentrates.
    Chistolini A; Mazzucconi MG; Tirindelli MC; La Verde G; Ferrari A; Mandelli F
    Acta Haematol; 1990; 83(3):163-5. PubMed ID: 2109459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombosis and disseminated intravascular coagulation following treatment with the prothrombin complex concentrate, DEFIX.
    Roddie PH; Stirling C; Mayne EE; Ludlam CA
    Thromb Haemost; 1999 Apr; 81(4):667. PubMed ID: 10235464
    [No Abstract]   [Full Text] [Related]  

  • 30. Massive, fatal, intracardiac thrombosis associated with prothrombin complex concentrate.
    Warren O; Simon B
    Ann Emerg Med; 2009 Jun; 53(6):758-61. PubMed ID: 19181420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative study of characteristics in the development of different toxigenic syndromes of disseminated intravascular blood coagulation].
    Barkagan ZS; Glazunova GA; Taranina TS
    Patol Fiziol Eksp Ter; 1988; (2):67-70. PubMed ID: 3412813
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition by recombinant hirudins of experimental venous thrombosis and disseminated intravascular coagulation induced by tissue factor in rats.
    Freund M; Cazenave JP; Courtney M; Degryse E; Roitsch C; Bernat A; Delebassée D; Defreyn G; Maffrand JP
    Thromb Haemost; 1990 Apr; 63(2):187-92. PubMed ID: 2363120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coagulation activation by lipopolysaccharides.
    Stief TW
    Clin Appl Thromb Hemost; 2009; 15(2):209-19. PubMed ID: 18160570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypercoagulable state and disseminated intravascular coagulation following an effective chemotherapy in tumor-bearing rats.
    Li H; Sasano Y; Hori K; Manabu K; Zhang Q; Saito S; Suzuki M
    Chin Med J (Engl); 1998 Oct; 111(10):951-5. PubMed ID: 11189247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prothrombin complex concentrate and fatal thrombosis: poor evidence to implicate a relatively safe drug.
    Sarode R; Matevosyan K
    Ann Emerg Med; 2009 Sep; 54(3):481-2; author reply 482-3. PubMed ID: 19695429
    [No Abstract]   [Full Text] [Related]  

  • 36. Hirudin in disseminated intravascular coagulation.
    Nowak G; Markwardt F
    Haemostasis; 1991; 21 Suppl 1():142-8. PubMed ID: 1894189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of potential thrombogenicity of coagulation factor IX concentrates in an in vitro model of human thrombogenesis.
    Galan AM; Reverter JC; Bozzo J; Hernandez MR; Escolar G; Aznar-Salatti J
    Thromb Res; 1999 Dec; 96(5):383-9. PubMed ID: 10605953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prothrombin complex concentrate (PCC) and its effect on reversing newer oral anticoagulants.
    Kappes J
    S D Med; 2012 Oct; 65(10):396-7. PubMed ID: 23098000
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypercoagulopathy induced by chemotherapy in a patient with lung cancer. A possible role for a factor with thrombosis-inducing activity (TIA).
    Hayashi S; Ogino H; Ogata K; Yagawa K
    Chest; 1992 Jan; 101(1):277-8. PubMed ID: 1729088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin and phenprocoumon inhibit kappa-carrageenin induced thrombosis in rats.
    Hirschelmann R; Bekemeier H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(3):379-82. PubMed ID: 2428713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.